StemBond Technologies

StemBond Technologies is a Cambridge, UK–based biomaterials company developing SENCE™, a synthetic, biomimetic cell-culture platform for regenerative medicine and cell therapy. Its ready-to-use surfaces are designed to replace rigid plastic and variable animal-derived matrices, helping researchers and developers generate more consistent, scalable, and biologically relevant cell outcomes in vitro.

Technology Developer